Postoperative rhabdomyolysis due to neuroleptic malignant syndrome associated with droperidol and metoclopramide

Anaesthesiol Intensive Ther. 2023;55(4):304-306. doi: 10.5114/ait.2023.132910.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiemetics* / adverse effects
  • Double-Blind Method
  • Droperidol / adverse effects
  • Humans
  • Metoclopramide / adverse effects
  • Neuroleptic Malignant Syndrome* / etiology
  • Postoperative Complications / etiology
  • Rhabdomyolysis* / chemically induced

Substances

  • Droperidol
  • Metoclopramide
  • Antiemetics